Casa Esperanza STRTP

Deficiency cited at inspection

On April 8, 2026, Licensing Program Analyst (LPA) Johanna Aracena conducted a case management investigation visit at Casa Esperanza STRTP-Chino. The purpose of the case management is to investigate an incident reported to the Department on April 6, 2026. The incident report stated that on 4/2/26, C1 stole the facility's vehicle and was gone on AWOL. The facility staff stated they didn't notice that C1 and the vehicle were missing until 9:15pm. Staff contacted law enforcement and reported C1's unauthorized absence and the theft of the vehicle as two different reports. During the inspection, LPA Aracena conducted a walkthrough of the facility and observed the facility is overall in compliance with Title 22 regulations. LPA Aracena obtained a copy of the LIC 500, Client Roster, C1' Needs and Services Plan and C1's Identification, Emergency Information form and staff contact information. LPA reviewed C1's file and found it to be in order. LPA interviewed three (3) staff members during the visit. During the visit, LPA Aracena informed the Facility Administrator that the Facility's Program Statement needs to be updated to ILS Version 6. No deficiencies were cited during this inspection. Based on the available information, there is not enough information to render a decision of the findings. A signed copy of this report was provided to the STRTP representative.

Deficiency cited at inspection

An unannounced Psychotropic Medication Inspection was conducted by Licensing Program Analysts (LPAs) Timika Martin Ashley Rouche and Pamela Silva on 1/29/26 at 9: AM. This case management inspection is conducted pursuant to Health and Safety Code Section 1538.9 (a)(2). During the inspection, LPAs met with CEO, Sukhwinder Singh and inspected the facility inside and out. There are no clients at this facility eligible for inspection due to the client prescribed psychotropic medication being placed in the facility for less than 30 days. LPAs reviewed 0 child record and 3 of staff personnel files on site at the facility. LPAs reviewed 0 child psychotropic medications and medication records. LPA interviewed 2 of staff on site to discuss the facility's policies and procedures of operation. LPA provided a copy of this licensing report to CEO, Sukhwinder Singh. No deficiencies are being cited at this time. LPA conducted exit interview with CEO, Sukhwinder Singh.

Deficiency cited at inspection

An unannounced Psychotropic Medication Inspection was conducted by Licensing Program Analysts (LPAs) Juliet Robles and Pamela Silva on 08/29/24 at 8: AM. This case management inspection is conducted pursuant to Health and Safety Code Section 1538.9 (a)(2). During the inspection, LPAs met with Glenda Gomez, Administrator, and inspected the facility inside and out. LPAs reviewed one (1) of child's records and three (3) of staff personnel files on site at the facility. LPAs reviewed one (1) of child's psychotropic medications and medication records. LPAs interviewed two (2) of staff on site to discuss the facility's policies and procedures of operation. LPAs interviewed (0) of child currently prescribed psychotropic medications. Child was unavailable and LPAs will conduct interview at a later date. No deficiencies are being cited at this time. LPAs conducted exit interview and provided a copy of this report to the Administrator, Glenda Gomez.